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Johannes Hauswaldt* , Eva Hummers-Pradier and Wolfgang HimmelAbstract
Background: An increase in a patient’s visits to doctors usually raises concerns and may be a ‘red flag’ for a
patient’s deterioration of health. The aim of this study was to analyze whether an increase of patient-physician
contacts is a first sign of a malignancy in a patient’s near future.
Methods: This is a retrospective case-control study. From 153 German general practices’ electronic patient records (EPR),
cases with at least one new malignancy diagnosis and no-malignancy controls were matched for gender and age. We
calculated (1) the number of contacts in the first quarter up to the sixth quarter before a malignancy diagnosis was
made and (2) the inter-contact interval (ICI), i.e. the time lag between two consecutive patient-physician contacts
measured in days. Differences between cases and controls were investigated in several analyses of variance, with group
and time as main factors.
Results: A total of 3,310 cases and 3,310 controls could be included. The number of contacts for cases in the six quarters
before a malignancy diagnosis increased from 4.8 contacts (SD 4.3) to 5.5 contacts (SD 4.8). The number of contacts for
controls increased only marginally from 4.3 contacts (SD 3.6) to 4.5 (SD 4.2). The factor ‘group’ (cases vs. controls) was
highly significant in the analyses of variance, also ‘time’ and the interaction ‘group * time’. The effect size, however, was
very small (R2 being less than 0.02), which is the equivalent for about one additional contact per quarter in cases directly
before a newly made malignancy diagnosis.
Conclusion: An increase in contact frequency is a call for GPs to become more attentive towards these patients. It may
raise the suspicion of an impending serious disease but the increase is not so dramatic and unique that it
can be interpreted a reliable sign of a malignant diagnosis.
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How this fits in
(1) Rapid increase in patient’s health care utilization in relation to
proximity of death and of severe illness is well known.
(2) On basis of German electronic patient records (EPR), we confirmed
increased patient contact frequencies in primary care before a first
malignancy diagnosis was made. This tendency started already
several quarters before the diagnosis. However, the effect size of this
trend was very small so that we cannot recommend any specific
action for GPs from this.
(3) Elaborated data analysis was needed for validation of results and
for any specific recommendations
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Rapid increase in patient’s health care utilization in
proximity of death is well known [1–4]. For example, in
a UK case-control study in primary care, clinical features
of colorectal cancer peaked out before diagnosis [5].
Studies on Danish register data also showed an increase
in contacts to physicians and consumption of health care
resources during one to six months before a first diagno-
sis of cancer was made [6, 7]. In another Danish study,
the GPs’ suspicion of cancer or other serious diseases
was associated with increase in a patient’s healthcare use
and diagnoses of serious disease [8].
Most of these studies were performed with the aim to
guide health care resource allocation and communica-
tion between primary and secondary care. Another aim
was to avoid delays in diagnosing cancer, attempts in thele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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patient’s pathway from first signs and symptoms of
cancer to diagnosis and treatment.
However, before we motivate GPs to consider every in-
crease in visits as a first sign or ‘red flag’ of a serious dis-
ease and thus to avoid late diagnosis in cancer and
referrals to specialists, we should validate former find-
ings and determine at which time contact frequencies in
case of a later cancer diagnosis increase in primary care
and how strong this increase is.
Although cancer is among the leading causes of death
worldwide (Global Burden of Disease 2015), incident
cases of cancer are not a frequent reason for encounter
in primary care. This study takes advantages of a large
data set of routine data from German general practices
so that enough cases can be expected to test the hypoth-
esis that patients visit their GP more frequently several
months before a malignancy is detected.
The aim of this study was to analyze whether an in-
crease of patient-physician contacts can be observed
during the six quarters (=18 months) before a diagnosis
of malignancy is made and if an increase of visits is a




This is a retrospective case-control study, using routine
data from electronic patient records (EPR) of 153 German
general practices, covering the years between 1996
and 2006. Additional information about the database
can be found in a previous report on frequency of
attendance [11].
Patients
Patients for this study were selected from anonymized
raw data in two steps. First, all persons who had at least
one ICD-10 malignancy diagnosis ever were identified.
Second, we wanted to make sure that all of them were
regular patients of the practice, and not emergency pa-
tients or patients on holiday etc. from other periods. As
‘cases’ only those were included who had at least one
contact during the 18 months (540 days) before first
documentation of a cancer diagnosis. A searching algo-
rithm was developed (see Additional file 1) to identify
the same number of persons matched for gender and
age but without any malignancy diagnosis (‘controls’)
and also having at least one visit to the practice within
the six quarters prior to the quarter of first cancer diag-
nosis of their matched case.
The quarter in which the first diagnosis of cancer was
documented was labelled q0. Due to characteristics of
electronic databases in German primary care, we could
only determine the quarter in which a patient receivedhis or her first malignancy diagnosis, but not the exact
date. This also was the reason not to include contact
data from the index quarter (q0), as in this quarter we
were unable to discern patient’s visits which occurred
before a diagnosis of malignancy was made from those
occurring after diagnosis.
Calculation of contact frequencies
The main criterion of this study was the number of
contacts before the malignancy diagnosis. To estimate
possible differences in visits between the period immedi-
ately before and long before the malignancy diagnosis as
well as possible differences in visits between cases and
controls, we calculated two measures for cases and, ac-
cordingly, for controls:
(1)The total number of contacts in the first quarter
up to the sixth quarter before q0, i. e. the quarter
in which a new malignancy diagnosis was first
documented.
(2)The inter-contact interval (ICI), i.e. the time lag
between two consecutive patient-physician contacts
measured in days. Lower values of ICI are equivalent
to higher contact frequencies, i.e. more frequent
visits. We recently showed the advantages using
the inter-contact interval as a tool in analysis of
health service consumption [11]. Mean inter-contact
intervals were calculated for six annual quarter
periods, prior to q0, for those patients, who had
at least one contact in each of the six quarters,
and compared within cases and between cases
and controls.
Statistical analysis
We first report and compare the absolute and relative
frequencies of the visits in each of the six quarters
before the malignancy diagnosis and in analogy for the
controls. Prior to further statistical analysis, the distribu-
tion of all values of interest was checked for normal
distribution using the Shapiro-Wilk test with a cut-off of
p = 0.05, and a parallel graphical discrimination via a
standardized normal probability plot (P-P plot).
The main hypothesis was to be tested in a set of two-
way analyses of variance (ANOVA), with group (cases
vs. controls) and time (directly before diagnosis vs. long
before, i.e. one year before diagnosis) as main factors.
Since it was an unbalanced design, we intended to use
the type III sum of square squares to determine F and
its respective p-value [12]. Gender was introduced as a
covariate. As measures of effect, we calculated the coeffi-
cient of determination, R2, the non-linear correlation coeffi-
cient eta-squared, and partial eta-squared. Additionally, an
analysis of variance with contact frequencies as repeated
measurements [13] was used for a subsample of cases and
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last six quarters prior to q0.
If the values of interest were not normally distributed
the scaling of the variables was to be modified by an
adequate transformation, e. g. a log transformation.
Stata 12 was used for all statistical calculations and
graphical display.Results
The sample
A total of 3,310 patients in our sample had at least one
malignancy diagnosis and at least one practice visit
within the six quarters (540 days) prior to the first day
of the index quarter of their first new malignancy diag-
nosis. These ‘cases’ were matched with 1,485 male and
1,825 female patients most similar with respect to age
(‘controls’). To gain these 3,310 control matches, all pa-
tients from the raw sample without any malignancy
diagnosis ever had to be run 89 times through a generic
identification algorithm (see Additional file 1).Contact frequencies
Figure 1 shows the mean number of patient contacts per
quarter, separated for cases and controls and separated for
all patients vs. a subsample of those who visited their GP at
least once in each of the last six quarters prior to the index
quarter. This subsample consisted of 718 controls, with 429
females (59.8 %), and 970 cases, with 569 females (58.7 %).Fig. 1 Mean contact frequency, six annual quartersThe number of visits for cases in the complete sample in-
creased, on average, from 4.8 contacts (SD 4.3) to 5.5 con-
tacts (SD 4.8) per quarter; the number of contacts for
controls increased, on average, only marginally from 4.3
contacts (SD 3.6) to 4.5 (SD 4.2). The result was similar for
those who visited their GP at least once in each of the last
six quarters (subsample), with a considerable increase for
cases from 5.4 (SD 4.5) to 6.3 (SD 4.7) and a slight increase
for controls from 5.0 (SD 3.8) to 5.5 (SD 4.7) per quarter.
Changes in inter-contact intervals (ICI)
In the next step, we compared the ICI over time and be-
tween cases and controls. The ICI for controls remained
nearly stabile during the whole study period. For example,
controls had, on average, an ICI of 52.5 days (SD: 101.4;
median: 25.5) in the sixth quarter before the index one, and
it was nearly the same in the quarter prior to the index one
(53.0; SD: 105.0; median: 26). In contrast, the average ICI
for cases was 45.3 days in the sixth quarter (SD: 94.3;
median: 24.5) and decreased to 41.3 days (SD: 84.5; median:
20.5) in the quarter directly before the diagnosis. In in other
words, not only visited these patients their GP in shorter
intervals just before they received a malignancy diagnosis;
compared to their matched cases, they also visited their GPs
in shorter intervals already six quarters before diagnosis.
Analysis of variance in contact frequencies
Since our main criterion, visits per quarter, was not nor-
mally distributed, we log-transformed the values and then
Table 1 ANOVA, contacts in quarter-2 vs. quarter-1
Source df Mean square F statistic Pr > F
Model 4 3.83 27.91 < 0.0001
Error 9,377 0.14
Gender 1 0.07 0.50 0.4773
Case/control 1 14.08 102.55 < 0.0001
Quarter 1 0.30 2.21 0.1376
Case/control*Quarter 1 0.43 3.12 0.0775
3,310 cases and 3,310 controls
Dependent variable: Number of contacts per quarter, logarithm
Effect size adjusted R2 = 0.0113
* linking two independent variables is to indicate their interaction term
included in the ANOVA modelling equation
Table 3 Repeated-measures ANOVA, 6 quarters: between-subject
effects
Source df Mean square F statistic Pr > F
Gender 1 0.01 0.00 0.9903
Case/control 1 608.1 8.39 0.0038
Gender*Case/control 1 103.09 1.42 0.2335
Error (contacts) 1,684 72.57
970 cases and 718 controls
Dependent variable: number of contacts per quarter, logarithm
Effect size R2 = < 0.01
* linking two independent variables is to indicate their interaction term
included in the ANOVA modelling equation
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factors ‘group’ (cases vs. controls) and ‘time’. Gender was
introduced as a covariate. When comparing the first vs. the
second quarter (Table 1), the factor 'group' was significant
with an impressive F value (F = 102.6; p < 0.0001). When
comparing the first vs. the sixth quarter (Table 2), the fac-
tor 'group' was still significant, with a high F value (59.9).
‘Time’ and the interaction ‘group * time’ were also signifi-
cant, but only when comparing first quarter vs. sixth quar-
ter (Table 2). However, the effect size in both analyses of
variance was very small, with R2, the population squared
multiple correlation, of 0.011 and 0.012, respectively and
an eta-squared, the overall non-linear correlation coeffi-
cient, of 0.01 for both. Accordingly, the effect sizes for all
independent factors, the partial eta-squared values, were
also smaller than 0.01.
Analysis of contact frequencies over six quarters as
repeated measures
We performed a further analysis of variance with contact
frequencies during the six quarters before q0 as repeated
measures for those patients only who had consulted their
GP in each of the six quarters under study. Table 3 shows
the 'between effect', with 'group' being significant (F = 8.4;Table 2 ANOVA, contacts in quarter-6 vs. quarter-1
Source df Mean square F statistic Pr > F
Model 4 3.24 24.19 < 0,0001
Error 7,852 0.31
Gender 1 0.10 0.77 0,3787
Case/control 1 7.95 59.32 < 0,0001
Quarter 1 0.86 6.38 0,0115
Case/control*Quarter 1 1.20 8.95 0,0028
3,310 cases and 3,310 controls
Dependent variable: Number of contacts per quarter, logarithm
Effect size adjusted R2 = 0,0117
* linking two independent variables is to indicate their interaction term
included in the ANOVA modelling equationp < 0.0038). Table 4 shows the 'within effect', with 'time'
being significant and a rather high F value (F= 12.7,
p <0.0001) together with a slight interaction with group. But
the effect sizes were, again, extremely small (Tables 3 and 4).
Discussion
Summary of main findings
Patients visited their GP more often during the time
period immediately before a first malignancy diagnosis
was made, compared to earlier periods. This is the result
of a retrospective observational study, incorporating
routine data from German general practices’ EPR into a
case-control design. The changes over time as well as
the differences between cases and controls were highly
significant but the effects were not very impressive, with
an average increase of about 1 contact per quarter or, in
terms of inter-contact intervals, a decrease of about six
days between two consecutive consultations.
Strengths and limitations of the study
The results of this study are based on a large sample of
primary care patients whose visits are well-documented
because data are also used for billing and reimbursement
of medical services. Due to the retrospective character of
the study, the behavior of both patients and GPs is not
influenced by any observational effects so that the visitTable 4 Repeated-measures ANOVA, 6 quarters: within-subject
effects
Source df Mean square F statistic Pr > F
Contacts 5 102.23 12.72 <
0.0001
Contacts*Gender 5 4.75 0.59 0.7067
Contacts*Case/control 5 19.15 2.38 0.0361
Contacts*Gender*Case/
control
5 12.06 1.5 0.1861
Error (contacts) 8,420 8.04
970 cases and 718 controls
Dependent variable: number of contacts per quarter, logarithm
Effect size R2 = < 0.01
* linking two independent variables is to indicate their interaction term
included in the ANOVA modelling equation
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same time unobtrusive.
The study sample is a convenience sample from rou-
tine data of general practices located in different parts of
Germany and is covering the time period from 1996 to
2006. This sample, which has been used in prior studies
[11, 14], cannot be considered to be representative for
all German GPs.
Patient’s contacts to the GP were derived from fee-for-
service data and other information in this rich and com-
prehensive routine data sample. Nevertheless, there may
have been additional visits which were not recorded in
these EPR service data, so calculation of inter-contact
intervals (ICI) and contact frequencies may err on the
conservative side [14].
First diagnosis of any malignancy was taken from first
appearance of respective ICD code, from chapter 2
(“Neoplasms”). We did not stratify the sample according
to entities. We did not extend our studies for first ap-
pearance of any other serious disease than malignancy.
For this last reason, again our results may err on the
conservative side, as other serious reasons may induce a
patient’s increased visits with the GP as well but this
patient has been subsumed under the controls.
Routine data from German practice information sys-
tems yield confirmed ICD codes on quarter of a year
base only. For this reason we used the annual quarter of
a patient’s first malignancy detection as a proxy for refer-
encing contacts and inter-contact intervals. This may
have caused a slight bias and conservative error, as for
this index quarter (q0) we were unable to discern pa-
tient’s contacts which occurred before a diagnosis of
malignancy was made from those occurring after diag-
nosis and for this reason had to exclude completely
contact data from this quarter.
German laws on privacy protection and data security
grossly limit secondary use and analysis of primary data
from routine health care, in contrast to many other
countries, for example Denmark with a comprehensive
national register [15], or the United Kingdom with a pri-
mary care data base derived from routinely recorded
electronic patient records [16]. In spite of these regula-
tions, we received ethical approval to gain pseudony-
mized routine data for the years 2001 to 2003 and 2006
to 2007 via a mandatory software interface from elec-
tronic patient records of more than 160 general practices
in Germany. These data are the base of this study. We
are optimistic that we will have access to new data in
two or three years but so long our data are the only ones
available to perform such an analysis. It seems to be rea-
sonable to assume that the main results of our study-
namely that visits increase significantly over the quarters
directly before a malignancy diagnosis is made, but effect
size is rather small-could be confirmed if the analysis isrepeated with data from a more recent period of
observation.
Comparison with literature
Our analysis from GPs’ routine data showed an increase in
visits of patients to their GP prior to first malignancy diag-
nosis. While population-based case-control studies from
the UK [5] and Denmark [6, 7] showed similar trends
shortly before the diagnosis, our study demonstrates that
these trends can be observed in primary care practices even
longer times before, at least for some patients.
Although the modelled differences were highly signifi-
cant in our sample, the effect size of the increase in
contact frequencies was very small and far less impres-
sive than the fourfold up to tenfold increase [5], or
even more [6] reported in other studies. According to
Christensen et al. [7], cancer patients had twice as many
consultations with their general practitioner (GP) 3
months before their diagnosis, ten to eleven times more
diagnostic investigations and five times more hospital
contacts than the reference population. Here the de-
mand for GP services peaked 1 month before diagnosis.
One reason for our lower rate of increase may be the
use of a single type primary data source, in contrast to
the cumulative data and parameter acquisition by the
other studies, thus for example missing those rapidly or
seriously ill patients who can by-pass their GP and enter
secondary and specialist care rather easily in Germany
[17]. Another reason may be that German patients in gen-
eral have a high annual base rate in visiting their GP when
compared to patients from other countries, with about ten
consultations per capita in 2012 in Germany, compared to
about five consultations in the UK or Denmark [18].
In contrast to other studies (e.g. [3, 4, 7]) which con-
sidered several outcomes, such as contacts and re-
sources, our analysis was limited to contacts only since
we wanted to recognize whether visits of patients prior
to malignancy diagnosis start to increase at a certain
point of time. However, this could not be determined by
our study. Rather, a uniform increase happened over the
six quarters under study, and possibly before. This was
also confirmed by our analyses of variance where the
interaction of time and group (cases vs. controls) was
only significant when we compared the first vs. the sixth
quarter before diagnosis of a malignancy but not when
comparing the first vs. the second quarter. Conse-
quently, time was highly significant in the analysis of
variance with contact frequencies as repeated measure-
ments over six quarters. In other words, our study con-
firmed an increase in visits of cancer or pre-cancer
patients but this seems to be a gradually incrementing
development, on average, and not a sudden step-like in-
crease some weeks or months before a definite diagnosis
was made.
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Every physician should and will be alerted when a
known patient visits him more frequently than is to be
expected from the patient’s own prior history. Observing
this may arouse suspicion that a serious unknown med-
ical problem may be the cause for a change in consult-
ation behavior. And it may be attractive to formulate
our preliminary findings as a rule: If a patient’s average
contact frequency derived from his last six (or more)
visits to the GP is higher than the average from the same
amount of preceding visits, the GP may expect a diagno-
sis of malignancy in this patient. But this rule would be
far too simple and, what is even more important, dan-
gerous. The increase in visits is not so dramatic that it
could help to distinguish an alarming contact behavior
from a random increase, whatever the reason may be.
Richards [9] described a similar dilemma from the
National Awareness and Early Diagnosis Initiative, con-
sidering the many symptoms that could possibly be due
to cancer. At which point should a GP reassure, observe,
request investigations or refer to specialist services? In
other words, the measure-be it contact frequencies or
symptoms-is not specific enough, may raise “false alarm”
and cause over-diagnosis when labelling patients as cancer
or pre-cancer candidates without sufficient evidence.
This is unsatisfactory since there seems to be, indeed,
an increase in contact frequencies and contact inter-
vals in pre-cancer patients or patients with an un-
known malignancy diagnosis. Future research should
find out whether there are any additional characteris-
tics in consultation behavior or socio-demographic
data of patients that make the detection of a cancer
candidate more specific without alarming other pa-
tients. So far, the GP’s gut feeling remains a strong pre-
dictor of cancer, as a Danish study found out [10] and
the observation of increased contact frequencies may
support this gut feeling.
Conclusion
An increase in contact frequency before a malignancy
diagnosis is a call for GPs to become more attentive to-
wards these patients. However, the increase is not so
dramatic and unique that it can be interpreted as a reli-
able sign of a new malignancy diagnosis and does not re-
quire, as a general rule, any specific action from GPs.
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